Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Berobenatide

A Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or Obesity

Pfizer · Phase 3 · Recruiting · Enrollment 300

NCT07792954

ArmPopulationDoseWeeksEstimandWeight change
Berobenatide Medium Maintenance DoseObesity or overweightn/rn/rn/rn/r
Placebo Matched to Low-Dose BerobenatideObesity or overweightn/rn/rn/rn/r
Berobenatide Low Maintenance DoseObesity or overweightn/rn/rn/rn/r
Berobenatide High Maintenance DoseObesity or overweightn/rn/rn/rn/r
Placebo Matched to Medium-Dose BerobenatideObesity or overweightn/rn/rn/rn/r
Placebo Matched to High-Dose BerobenatideObesity or overweightn/rn/rn/rn/r